CAPRELSA
NDC 58468-7840, Vandetanib, tablet, film coated, from Genzyme Corporation.
- Product NDC
- 58468-7840
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022405
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-7840 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VANDETANIB300 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-7840-3 | 58468784003 | 1 BOTTLE, PLASTIC in 1 CARTON (58468-7840-3) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e5721cb8-4185-47b9-bbb3-1c587e558a03
Use it
Look up 58468-7840 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-7840 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-7840. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.